Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation

Thrombosis Research(2020)10.1016/j.thromres.2020.05.012Source: DataRank Database

Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation is a research paper published in Thrombosis Research (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.03)OA: greenTopics (35)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Scott L. Diamond ORCID,Yiyuan Zhang

Live enrichment

PubMed:32480168 PMC:PMC7306827 OpenAlex:https://openalex.org/W3024046505

NHLBI NIH HHS

Grant: R01 HL103419

NHLBI NIH HHS

Grant: U01 HL131053

National Institutes of Health

Grant: 1R01HL103419-01

Blood Systems Biology

National Institutes of Health

Grant: 5U01HL131053-05

Multiscale Analysis of Trauma

FWCI

1.03

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7306827

publisherhttps://api.elsevier.com/content/article/PII:S0049384820301845?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0049384820301845?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.thromres.2020.05.012

Fields of Study

Chronic Myeloid Leukemia TreatmentsPlatelet Disorders and TreatmentsCoagulation, Bradykinin, Polyphosphates, and Angioedema03 medical and health sciences0302 clinical medicine

MeSH Terms

DasatinibBlood PlateletsCollagenHumansThrombinsrc-Family Kinases

Keywords

DasatinibThrombinSykChemistryProto-oncogene tyrosine-protein kinase SrcPlateletFibrinClot retractionTyrosine kinaseSrc family kinasePlatelet activationPharmacologyKinaseMedicineInternal medicineImmunologySignal transductionBiochemistryCollagenThrombosisGpviBlood Plateletssrc-Family KinasesHumans

Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation

FAIR Checklist

Authors (2)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)